Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of GCS-100 to Treat Chronic Kidney Disease

This study has been completed.
Information provided by (Responsible Party):
La Jolla Pharmaceutical Company Identifier:
First received: October 26, 2012
Last updated: June 19, 2013
Last verified: June 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2013
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)